A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has achieved ... majority of patients because of the difficulty in finding a suitable match, the high cost of the procedure ...

What is happening today in Washington is a travesty. And the only ones who can prevent it from going further are the people ...

Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

Can generative AI (gen AI) rip things apart and then try to glue it all back together with more insight, more intelligence, more efficiency, and more value? It really depends on what the application ...

Walmart's week-long sale has plenty of deals—these are worth your moneyBy Consumer ReportsIf you’ve been waiting for a big ...

Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.70% to $511.74 Monday, on what proved to be an all-around great trading ...

Barry chats with Vertex Minerals' Roger Jackson about turning from explorer to producer and the psychology of gold mining. ... Read More The post Explorers Podcast: Vertex ready to claim its gold ...